ENMD-981693 Completed Phase 1 Trials for Multiple Myeloma (MM) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00806065Study of ENMD-2076 in Patients With Multiple Myeloma